In one aspect, compounds and associated pharmaceutical compositions are described herein for the treatment of various bacterial infections and/or other diseases. In some embodiments, for example, compounds of Formula (I) and/or salts thereof are described herein.

In one aspect, compounds and associated pharmaceutical compositions are described herein for the treatment of various bacterial infections and/or other diseases. In some embodiments, for example, compounds of Formula (I) and/or salts thereof are described herein.

This application relates to quinazoline derivatives, processes for their preparation, pharmaceutical compositions, and medical uses thereof.

This application relates to quinazoline derivatives, processes for their preparation, pharmaceutical compositions, and medical uses thereof.

A compound, a stereoisomer thereof, a hydrate thereof, or a pharmaceutically acceptable salt thereof, provided as one aspect of the present invention, exhibits a high inhibitory ability on euchromatic histone-lysine N-methyltransferase 2 (EHMT2), and thus, the compound can be usefully used for the treatment of cancer.

A compound, a stereoisomer thereof, a hydrate thereof, or a pharmaceutically acceptable salt thereof, provided as one aspect of the present invention, exhibits a high inhibitory ability on euchromatic histone-lysine N-methyltransferase 2 (EHMT2), and thus, the compound can be usefully used for the treatment of cancer.

The present disclosure relates generally to a class of quinazoline compounds, compositions containing the same and the therapeutic use of the compounds in the treatment of cancer.

The present disclosure relates generally to a class of quinazoline compounds, compositions containing the same and the therapeutic use of the compounds in the treatment of cancer.

This application relates generally to toll like receptor modulator compounds and pharmaceutical compositions which, among other things, modulate toll-like receptors (e.g. TLR8), and methods of making and using them.

This application relates generally to toll like receptor modulator compounds and pharmaceutical compositions which, among other things, modulate toll-like receptors (e.g. TLR8), and methods of making and using them.